190 related articles for article (PubMed ID: 33749974)
1. Skewed Th17/Treg balance during progression and malignant transformation of oral submucous fibrosis.
Liu S; Liu Z; Shan Z; Liu Y; Chen T; Fang L; Quan H
Oral Dis; 2022 Nov; 28(8):2119-2130. PubMed ID: 33749974
[TBL] [Abstract][Full Text] [Related]
2. The expression of Th17/Treg in oral submucosal fibrosis carcinogenesis and the significance in the development of mucosal lesions.
Wu D; Liu X; Zhou T; Tan J
Cell Mol Biol (Noisy-le-grand); 2023 Sep; 69(9):84-88. PubMed ID: 37807330
[TBL] [Abstract][Full Text] [Related]
3. Change and pathological significance of glycogen content in oral squamous cell carcinoma and oral submucous fibrosis.
Nie H; Hu X; Xiong H; Zeng L; Chen W; Su T
Tissue Cell; 2024 Apr; 87():102337. PubMed ID: 38430849
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of programmed death-1 and its ligand, programmed death ligand-1 in oral squamous cell carcinoma with and without oral submucous fibrosis.
Quan H; Liu S; Shan Z; Liu Z; Chen T; Hu Y; Yao Z; Fang L
Arch Oral Biol; 2020 Nov; 119():104916. PubMed ID: 32977151
[TBL] [Abstract][Full Text] [Related]
5. Spatial Transcriptomic and Metabolomic Landscapes of Oral Submucous Fibrosis-Derived Oral Squamous Cell Carcinoma and its Tumor Microenvironment.
Zhi Y; Wang Q; Zi M; Zhang S; Ge J; Liu K; Lu L; Fan C; Yan Q; Shi L; Chen P; Fan S; Liao Q; Guo C; Wang F; Gong Z; Xiong W; Zeng Z
Adv Sci (Weinh); 2024 Mar; 11(12):e2306515. PubMed ID: 38229179
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
Varun BR; Ranganathan K; Rao UK; Joshua E
J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
[TBL] [Abstract][Full Text] [Related]
7. The Role of Increased Connective Tissue Growth Factor in the Pathogenesis of Oral Submucous Fibrosis and its Malignant Transformation-An Immunohistochemical Study.
Shah AM; Jain K; Desai RS; Bansal S; Shirsat P; Prasad P; Bodhankar K
Head Neck Pathol; 2021 Sep; 15(3):817-830. PubMed ID: 33544386
[TBL] [Abstract][Full Text] [Related]
8. An Evaluation of Clinical and Histopathological Aspects of Patients with Oral Submucous Fibrosis in the Background of Oral Squamous Cell Carcinoma.
Siriwardena BSMS; Jayawardena KLTD; Senarath NH; Tilakaratne WM
Biomed Res Int; 2018; 2018():4154165. PubMed ID: 30402477
[TBL] [Abstract][Full Text] [Related]
9. Low-dose arecoline regulates distinct core signaling pathways in oral submucous fibrosis and oral squamous cell carcinoma.
Li Z; Fu Y; Hu Y; Zhu Y; Hu L; Shi C; Zhang Y; Zhang J; Zhou S
BMC Oral Health; 2023 Mar; 23(1):171. PubMed ID: 36966276
[TBL] [Abstract][Full Text] [Related]
10. Low LINC02147 expression promotes the malignant progression of oral submucous fibrosis.
Chen J; Li W; Liu B; Xie X
BMC Oral Health; 2022 Jul; 22(1):316. PubMed ID: 35906577
[TBL] [Abstract][Full Text] [Related]
11. IRF4 as a novel target involved in malignant transformation of oral submucous fibrosis into oral squamous cell carcinoma.
Meng L; Jiang Y; You J; Zhao P; Liu W; Zhao N; Yu Z; Ma J
Sci Rep; 2023 Feb; 13(1):2775. PubMed ID: 36797470
[TBL] [Abstract][Full Text] [Related]
12. Oral Submucous Fibrosis: Etiological Mechanism, Malignant Transformation, Therapeutic Approaches and Targets.
Qin X; Ning Y; Zhou L; Zhu Y
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902423
[TBL] [Abstract][Full Text] [Related]
13. [A retrospective study of oral squamous cell carcinomas originated from oral submucous fibrosis].
Guo F; Jian XC; Zhou SH; Li N; Hu YJ; Tang ZG
Zhonghua Kou Qiang Yi Xue Za Zhi; 2011 Aug; 46(8):494-7. PubMed ID: 22169748
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of stromal myofibroblasts in oral submucous fibrosis and its malignant transformation: An immunohistochemical study.
Liu Z; Hu W; Shan Z; Liu S; Yao Z; Quan H
J Cancer Res Ther; 2024 Apr; 20(2):706-711. PubMed ID: 38687943
[TBL] [Abstract][Full Text] [Related]
15. Estimation of salivary matrix metalloproteinases- 12 (MMP- 12) levels among patients presenting with oral submucous fibrosis and oral squamous cell carcinoma.
Saleem Z; Shaikh AH; Zaman U; Ahmed S; Majeed MM; Kazmi A; Farooqui WA
BMC Oral Health; 2021 Apr; 21(1):205. PubMed ID: 33892690
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological characteristics of oral squamous cell carcinoma arising from oral submucous fibrosis: A systematic review.
Divya B; Vasanthi V; Ramadoss R; Kumar AR; Rajkumar K
J Cancer Res Ther; 2023; 19(3):537-542. PubMed ID: 37470571
[TBL] [Abstract][Full Text] [Related]
17. MALDI imaging reveals NCOA7 as a potential biomarker in oral squamous cell carcinoma arising from oral submucous fibrosis.
Xie X; Jiang Y; Yuan Y; Wang P; Li X; Chen F; Sun C; Zhao H; Zeng X; Jiang L; Zhou Y; Dan H; Feng M; Liu R; Chen Q
Oncotarget; 2016 Sep; 7(37):59987-60004. PubMed ID: 27509054
[TBL] [Abstract][Full Text] [Related]
18. Ki67, CD105, and α-SMA Expression Supports Biological Distinctness of Oral Squamous Cell Carcinoma Arising in the Background of Oral Submucous Fibrosis.
Gadbail AR; Korde S; Chaudhary MS; Sarode SC; Gondivkar SM; Dande R; Tekade SA; Yuwanati M; Hande A; Patil S
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2067-2074. PubMed ID: 32711434
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of CK8 and CK18 in leukoplakia, oral submucous fibrosis, and oral squamous cell carcinoma: an immunohistochemistry study.
Nanda KD; Ranganathan K; Devi U; Joshua E
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Feb; 113(2):245-53. PubMed ID: 22677743
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of oral squamous cell carcinoma with oral submucous fibrosis.
Saalim M; Sansare K; Karjodkar FR; Johaley S; Ali IK; Sharma SR; Mehra A; Rahman B
J Cancer Res Ther; 2021; 17(6):1510-1514. PubMed ID: 34916386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
